1-9 of 9
Beyond the Liver: The Cardiometabolic Impact of MASLD
Medical Industry FeatureBeyond the Liver: The Cardiometabolic Impact of MASLD
Nadege Gunn, MD, CPI, DABOM, FAASLD
Uncovering Metabolic Connections: Obesity, MASLD, and Heart Disease
Medical Industry FeatureUncovering Metabolic Connections: Obesity, MASLD, and Heart Disease
Robert F. Kushner, MD
Understanding Obesity: From Adiposity to Multi-Organ Impact
Medical Industry FeatureUnderstanding Obesity: From Adiposity to Multi-Organ Impact
Robert F. Kushner, MD
Recognizing the Liver: Understanding MASLD Risk in People with Metabolic Diseases
Medical Industry FeatureRecognizing the Liver: Understanding MASLD Risk in People with Metabolic Diseases
Nadege Gunn, MD, CPI, DABOM, FAASLD
Beyond the Scale: Reducing the Risk of Obesity Complications
Medical Industry FeatureBeyond the Scale: Reducing the Risk of Obesity Complications
Robert F. Kushner, MD
LDL-C Management in Focus: A Clinical Dialogue Between Experts
Medical Industry FeatureLDL-C Management in Focus: A Clinical Dialogue Between Experts
Jaime Burkle, MD, FACC, FNLA
M. Chadi Alraies, MD, FACC, FSCAI
- advertisement
Aiming to Stay Lower for Longer: Exploring the Clinical Evidence for Long-term LDL-C Reduction
Medical Industry FeatureAiming to Stay Lower for Longer: Exploring the Clinical Evidence for Long-term LDL-C Reduction
Andrew Freeman, MD, FACC, FACP
Lily Dastmalchi, DO
How GLP-1s Provide New Options to Manage Heart Disease
Medical Industry FeatureHow GLP-1s Provide New Options to Manage Heart Disease
David Majure, M.D., MPH
Rethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
Medical Industry FeatureRethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
Charles Turck, PharmD, BCPS, BCCCP
Jamy Ard, MD
Michelle I. Cardel, PhD, MS, RD
